Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Advances in multiple Sclerosis and Experimental Demyelinating Diseases-1

Moses Rodriguez
Editor

2008

There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis (MS). From the days of Charcot in the 1800s, MS has been pathologically characterized primarily by demyelination; that is, the loss of myelin with the relative preservation of axons.

Leave a Reply

Your email address will not be published. Required fields are marked *